← Back to Clinical Trials
Recruiting NCT06467916

NCT06467916 The Development of PATH, a Program to Support NICU Parent Mental Health Through the Transition From Hospital to Home

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06467916
Status Recruiting
Phase
Sponsor University of Colorado, Denver
Condition Perinatal Mental Health
Study Type INTERVENTIONAL
Enrollment 72 participants
Start Date 2025-04-22
Primary Completion 2026-04-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Behavioral Treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 72 participants in total. It began in 2025-04-22 with a primary completion date of 2026-04-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of this study is to develop and pilot test a telehealth-based mental health screening and engagement program that supports parents as their infants transition home from the NICU. The program will use a stepped-care approach to screen parents for depression, anxiety, and PTSD; provide a brief behavioral intervention to those who screen as having at least a low risk of these conditions; and provide a warm hand-off to community mental health services for those at medium to high risk.

Eligibility Criteria

Inclusion Criteria: * NICU parents: Participants will be parents of currently hospitalized preterm infants from either the OHSU NICU or the UCH NICU. We will include parents of live preterm infants who have been admitted in the NICU for at least 2 weeks. Parents must speak English or Spanish. Parents can be of any age. * NICU stakeholders: Participants will be stakeholders from either the OHSU NICU or the UCH NICU. Stakeholders will be social workers, mental health providers responsible for providing more intensive mental health support for NICU parents, nurses, neonatologists, and hospital administrators.

Contact & Investigator

Central Contact

Susanne Klawetter, PhD

✉ susanne.klawetter@cuanschutz.edu

📞 303-724-1646

Frequently Asked Questions

Who can join the NCT06467916 clinical trial?

This trial is open to participants of all sexes, studying Perinatal Mental Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06467916 currently recruiting?

Yes, NCT06467916 is actively recruiting participants. Contact the research team at susanne.klawetter@cuanschutz.edu for enrollment information.

Where is the NCT06467916 trial being conducted?

This trial is being conducted at Aurora, United States, Portland, United States.

Who is sponsoring the NCT06467916 clinical trial?

NCT06467916 is sponsored by University of Colorado, Denver. The trial plans to enroll 72 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology